NTRA Form 4: Steven Chapman Disposes 5,079 Shares via Rule 10b5-1
Rhea-AI Filing Summary
Natera, Inc. (NTRA) director and CEO Steven Leonard Chapman reported sales of 5,079 shares of Natera common stock on 09/02/2025 executed under a Rule 10b5-1 trading plan. The sales are reported on three lines with weighted-average prices disclosed in ranges: $164.93–$165.7750, $165.97–$166.90, and $167.41–$168.28. After these transactions Mr. Chapman beneficially owned 158,514 shares. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person and discloses that the trades were made pursuant to a plan adopted December 11, 2023 and amended December 2, 2024.
Positive
- Sales executed under a Rule 10b5-1 plan, which supports compliance and reduces timing concerns
- Detailed price ranges provided via weighted-average disclosures for transparency
- Reporting person retains substantial ownership with 158,514 shares remaining beneficially owned
Negative
- None.
Insights
TL;DR: Insider sold 5,079 shares under a pre-established 10b5-1 plan; holdings remain substantial at 158,514 shares.
The reported transactions are routine insider sales executed pursuant to an established Rule 10b5-1 plan, reducing concerns about opportunistic timing. The filing provides weighted-average price ranges for the multiple executions but does not list total proceeds. The remaining beneficial ownership of 158,514 shares indicates continued significant alignment with shareholder outcomes, while the sale size relative to total holdings appears modest based on the data provided.
TL;DR: Transactions followed a documented trading plan, which supports compliance and reduces governance red flags.
The Form 4 clearly indicates the trades were made under a 10b5-1 plan adopted December 11, 2023 and amended December 2, 2024, which is best practice for avoiding claims of insider-timing. The report is signed by an attorney-in-fact and includes explanatory footnotes on weighted-average price ranges. No indication of unusual or suspicious activity is present in the filing itself.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 1,700 | $165.4368 | $281K |
| Sale | Common Stock | 1,472 | $166.286 | $245K |
| Sale | Common Stock | 1,907 | $167.6872 | $320K |
Footnotes (1)
- The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023, as amended on December 2, 2024. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $164.93 to $165.7750 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $165.97 to $166.90 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $167.41 to $168.28 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.